A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
Clinical trial NCT04203797 · COMPLETED
Trial details
- NCT number
- NCT04203797
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-16
- Primary completion
- 2023-07-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.